About Us
We believe the future of healthcare is proactive, personalized, and data-driven. Our mission is to extend the healthy human lifespan through early detection and precision medicine.
Most people only see a doctor when something feels wrong. By then, the window for meaningful intervention has often closed. Human Longevity was built on a different premise: that biology gives us signals long before disease becomes visible — and that catching those signals early is the difference between prevention and treatment.
Our mission is to give every member the most complete picture of their health that science can provide — and the clinical team to act on it.
10,000+
Clients Served
400M+
Genetic Variants Cataloged
$600M
Invested in Research
75,000+
Genomes Sequenced
150GB+
Health Data Per Client
120+
Blood Biomarkers Measured
20+
Peer-Reviewed Publications
Est. 2013
Over a Decade of Science
Since 2013
In 2000, Dr. J. Craig Venter made history by sequencing the first human genome alongside NIH consortium partners — marking the beginning of the genomic revolution and a new era of precision medicine.
Co-Founder
Dr. J. Craig Venter

Dr. Venter pioneered the sequencing of the first human genome in 2000 — a scientific landmark that redefined what medicine could know about the human body. He founded Human Longevity in 2013 to translate that science into real clinical care.
His vision: shift medicine from reactive to proactive. Detect disease before it becomes symptomatic. Give every person a complete biological picture of themselves — and the tools to act on it.
Key Milestones
2000
Dr. Venter sequences the first human genome
Dr. J. Craig Venter completed the first sequence of the human genome — a landmark that permanently redefined the future of medicine and what science could know about the human body.

2013
Human Longevity, Inc founded by Dr. Venter
Dr. Venter founded Human Longevity to apply the power of genomic science to individual health — detecting disease before symptoms ever appear.

2015
San Diego Longevity Care clinic opens
HLI's flagship precision medicine clinic opened in San Diego — the first to offer whole-body MRI, genomic sequencing, and deep biomarker analysis in a single integrated visit.

2019
Partnership with MGH; launch of Simplify Genomics
Human Longevity partnered with Massachusetts General Hospital and launched Simplify Genomics, expanding access to clinical-grade genomic analysis.

2020
Landmark PNAS publication; 100+ Longevity Programs
HLI published landmark precision medicine research in PNAS and introduced the 100+ Longevity Programs — a new standard in proactive health membership.

2022
San Francisco HQ and clinic opens
Human Longevity expanded to San Francisco, opening a new headquarters and clinic to serve the Bay Area and a new generation of health-conscious leaders.

Scientific Advisory Board

Aubrey de Grey, PhD
Biomedical Gerontologist
Developer of the SENS framework — a roadmap for reversing the cellular damage that drives aging.

Michael Levitt, PhD
Nobel Laureate · Chemistry
2013 Nobel Prize in Chemistry for multiscale computational models of chemical systems.

Geoffrey Hinton, PhD
Nobel Laureate · AI Pioneer
The "Godfather of Deep Learning" — 2024 Nobel Prize in Physics for foundational AI research.
Research
Ranked Top 50 Biomedical Companies Globally by Nature Index. Over 20 peer-reviewed publications in Nature Genetics, PNAS, AJHG, and Genome Medicine. Our science isn't theoretical — it directly informs how we care for every client.
PNAS
2020
Venter JC, et al.
Demonstrating HLI's approach to phenotypic aging analysis — the scientific foundation behind our health intelligence platform.
Click to browse
Partners
Trusted by the world's top institutions
We collaborate with leading research centers, diagnostic innovators, and clinical networks to bring the highest standard of care to every client.
And More